We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
80.67%
This Fund
S&P 500
This Quarter
Est. Return
+31.44%
1 Year Est. Return
+80.67%
3 Year Est. Return
+80.2%
5 Year Est. Return
+49.87%
10 Year Est. Return
+446.13%
AUM
$719M
AUM Growth
-$27.1M
(-3.6%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-29.53%
Top 10 Holdings %
Top 10 Hldgs %
66.29%
Holding
201
New
72
Increased
18
Reduced
27
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$7.93M |
| 2 |
FNB Corp
FNB
|
+$7.61M |
| 3 |
Sherwin-Williams
SHW
|
+$7.06M |
| 4 |
Allstate
ALL
|
+$5.58M |
| 5 |
Willis Towers Watson
WTW
|
+$5.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$274M |
| 2 |
Celanese
CE
|
+$6.41M |
| 3 |
MON
Monsanto Co
MON
|
+$6.27M |
| 4 |
Bunge Global
BG
|
+$5.97M |
| 5 |
Air Products & Chemicals
APD
|
+$4.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.96% |
| 2 | Financials | 20.91% |
| 3 | Industrials | 5.93% |
| 4 | Technology | 5.51% |
| 5 | Communication Services | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Affiliated Managers Group
AMG
$9.05B
| – | – |
-16,047
| Closed | -$2.66M |
|
|
127
Air Products & Chemicals
APD
$64.2B
| – | – |
-32,500
| Closed | -$4.65M |
|
|
128
Bunge Global
BG
$23.5B
| – | – |
-80,000
| Closed | -$5.97M |
|
129
Blue Bird Corp
BLBD
$1.97B
| – | – |
-45,569
| Closed | -$775K |
|
130
BioMarin Pharmaceuticals
BMRN
$12.5B
| – | – |
-22,592
| Closed | -$2.05M |
|
131
Brown & Brown
BRO
$22.6B
| – | – |
-12,664
| Closed | -$273K |
|
|
132
CALL
Celanese
CE
$5.17B
| – | – |
-1,000
| Closed | -$280K |
|
|
133
Celanese
CE
$5.17B
| – | – |
-67,500
| Closed | -$6.41M |
|
134
Citizens Financial Group
CFG
$29.5B
| – | – |
-60,000
| Closed | -$2.14M |
|
135
Cigna
CI
$76.5B
| – | – |
-7,209
| Closed | -$1.21M |
|
|
DBVT
136
DBV Technologies
DBVT
$740M
| – | – |
-721
| Closed | -$257K |
|
137
CALL
Eastman Chemical
EMN
$7.5B
| – | – |
-1,500
| Closed | -$454K |
|
138
Enovis
ENOV
$1.04B
| – | – |
-26,105
| Closed | -$1.77M |
|
139
East-West Bancorp
EWBC
$17.6B
| – | – |
-23,800
| Closed | -$1.39M |
|
140
Exponent
EXPO
$3.2B
| – | – |
-56,900
| Closed | -$1.66M |
|
141
Factset
FDS
$9.88B
| – | – |
-19,605
| Closed | -$3.26M |
|
142
Fair Isaac
FICO
$21.3B
| – | – |
-16,545
| Closed | -$2.31M |
|
143
PUT
GE Aerospace
GE
$320B
| – | – |
-522
| Closed | -$210K |
|
144
Gilead Sciences
GILD
$181B
| – | – |
-50,881
| Closed | -$3.6M |
|
145
Generac Holdings
GNRC
$10.3B
| – | – |
-47,294
| Closed | -$1.71M |
|
146
HCA Healthcare
HCA
$91.5B
| – | – |
-7,209
| Closed | -$629K |
|
|
HEES
147
DELISTED
H&E Equipment Services
HEES
| – | – |
-61,071
| Closed | -$1.25M |
|
148
Herc Holdings
HRI
$4.63B
| – | – |
-15,733
| Closed | -$619K |
|
149
Humana
HUM
$47.4B
| – | – |
-7,212
| Closed | -$1.74M |
|
150
Intercontinental Exchange
ICE
$88.3B
| – | – |
-17,242
| Closed | -$1.14M |
|
Similar funds
OM
ICCON
HCM
ETCM
IDBONY
PCM
TCDRS
FPAM
Crestline Management's Q3 2017 Portfolio in Review
As of Q3 2017, Crestline Management held 201 positions worth $719M, down 3.6% from $746M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Crestline Management withdrew a net $212M in Q3 2017, closing 81 positions and reducing 27 holdings. Its most notable exit was Celanese, an estimated $6.41M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 76% a quarter earlier, followed by Financials and Industrials.
Against the trend, Crestline Management opened a new position in Travelers Companies worth $7.78M.
- Crestline Management's largest Q3 2017 buy was Travelers Companies: 63,503 shares worth $7.78M.
- Crestline Management added most to FNB Corp in Q3 2017, an estimated $7.61M increase.
- Crestline Management's biggest Q3 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $274M.
- Crestline Management fully exited Celanese in Q3 2017, selling an estimated $6.41M.
- Crestline Management's ten largest holdings make up 66% of its $719M portfolio in Q3 2017.
- Crestline Management opened 72 new positions and closed 81 in Q3 2017.
- Crestline Management's portfolio value fell 3.6% quarter-over-quarter to $719M.
Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.